| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce5c5b6130b6839f960491acadd564b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4bfd608907044be1dd8a39dc7dac311b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_279ec0a73b4cd9054c8b465e30c9cf99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_80dbfb35f896d69e6fb6eaee30231a09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e32b8e5c1871fe658d75728d45feeb57 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-531
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2330-51 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1138 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate |
2009-01-30^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0dca3dc89220f486fb3990e02dcda9fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42d2ecf1e359f5f5ee69839bedb41628
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe5ed2d830bcf2697804e900eba85c59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f72b129b6b7fc8221c08fdd162145a5 |
| publicationDate |
2009-08-13^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009099959-A2 |
| titleOfInvention |
Tumor cell expression of neuropilin as a target for cancer therapy |
| abstract |
Disclosed are compositions that include a nucleic acid component that include a nucleic acid that inhibits the expression of a gene that encodes a neuropilin, and a lipid component that includes one or more neutral phospholipids. Also disclosed are compositions that include a nucleic acid component that includes a nucleic acid that inhibits the expression of a gene that encodes neuropilin-2 (NRP-2). Also disclosed are methods of treating a subject with cancer that involve administering to the subject a pharmaceutically effective amount of a composition of the present invention. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2522341-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9540439-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012156289-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108196071-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2823816-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014058915-A3 |
| priorityDate |
2008-01-31^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |